Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251) + Azelaic Acid Cream + Metronidazole gel + Metronidazole cream + Metronidazole Emulsion + Metronidazole Lotion + Brimonidine Tartrate Gel
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Rosacea
Conditions
Rosacea
Trial Timeline
Jan 8, 2015 → Mar 10, 2016
NCT ID
NCT02602470About Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251) + Azelaic Acid Cream + Metronidazole gel + Metronidazole cream + Metronidazole Emulsion + Metronidazole Lotion + Brimonidine Tartrate Gel
Azelaic Acid Gel including: Finacea (Azelaic Acid Gel 15%, BAY39-6251) + Azelaic Acid Cream + Metronidazole gel + Metronidazole cream + Metronidazole Emulsion + Metronidazole Lotion + Brimonidine Tartrate Gel is a pre-clinical stage product being developed by Bayer for Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT02602470. Target conditions include Rosacea.
Hype Score Breakdown
Clinical
5
Activity
2
Company
7
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02602470 | Pre-clinical | Completed |
Competing Products
20 competing products in Rosacea